author-photo

Petra Gorombei

Paris Diderot University

13

Papers

65

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome

2021 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (0)
The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1

2018 Cell Death & Differentiation
Show All
- Source
- Cite
- Save
Citations (17)
Additional file 3: Figure S2. of GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways

2016
Show All
- Source
- Cite
- Save
Citations (0)
GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.

2016 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (7)
pVAX14 DNA, a Non-Specific DNA Vaccine, Improves Survival In An Acute Promyelocytic Leukemia (APL) Mouse Model Treated With All-Trans Retinoic Acid (ATRA) and Arsenic Trioxide (ATO) and Targets Leukemia Initiating Cells (LICs)

2013 Blood
Show All
- Source
- Cite
- Save
Citations (0)
BCL-2 Inhibition with ABT-737 Prolongs Survival in an NRAS/BCL2-Mediated MOUSE MODEL of Myelodyspastic Syndrome (MDS) Progressing to ACUTE Myelogenous Leukemia (AML) by Targeting Leukemia Initiating CELLS

2012 Blood
Show All
- Source
- Cite
- Save
Citations (0)